EUVIMEDEUVIMED entdecken
Crossref

Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab ( PCC ) regimen for metastatic or unresectable head and neck squamous cell carcinomas

Margaret Locke iD, Nina Kohn iD, Nagashree Seetharamu iD

Clinical Otolaryngology · 2023

DOI: 10.1111/coa.14091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Otolaryngology, 2023. Verfasst von Margaret Locke und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Institutional Review Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansCarboplatinCetuximabCisplatinNeoplasm Recurrence, LocalPaclitaxelTreatment Outcome

Stichwörter der Autor:innen

chemotoxicityhead and neck cancermetastatic diseaseunresectable head and neck cancer

Substanzen

CarboplatinCetuximabCisplatinPaclitaxel

Autor:innen und Institutionen

  • Department of Internal Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.
  • Office of Academic Affairs, Northwell Health, Manhasset, New York, USA.
  • Monter Cancer Center, Northwell Health, Manhasset, New York, USA.

ORCID-Profile: Margaret Locke, Nina Kohn, Nagashree Seetharamu

Förderung

  • Institutional Review Board

Zitieren

APA

Locke, M., Kohn, N., & Seetharamu, N. (2023). Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab ( PCC ) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clinical Otolaryngology. https://doi.org/10.1111/coa.14091

Vancouver

Locke M, Kohn N, Seetharamu N. Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab ( PCC ) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clinical Otolaryngology. 2023. doi:10.1111/coa.14091

BibTeX
@article{Locke2023,
  author = {Locke, Margaret and Kohn, Nina and Seetharamu, Nagashree},
  title = {Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab ( PCC ) regimen for metastatic or unresectable head and neck squamous cell carcinomas},
  journal = {Clinical Otolaryngology},
  year = {2023},
  doi = {10.1111/coa.14091}
}
Kostenlos starten →